SPY736.53+0.17%QQQ657.50+0.21%BTC/USD74,526.23−1.61%DIA512.52+0.06%GLD373.37+0.23%TLT81.85−0.09%
BenzingaPremium Services
Premium Services

Dan Ahrens

Dan Ahrens is the managing director of AdvisorShares, a U.S.-based investment firm specializing in actively managed exchange-traded funds. He serves as portfolio manager for several cannabis-focused ETFs, including the AdvisorShares Pure Cannabis ETF, guiding investment strategies in the emerging legal cannabis market. Ahrens has extensive experience in fund management and sector-specific investing.

EXCLUSIVE: Cannabis ETF Leaders Highlight Convenience For Investors, Growth Opportunities — 'I Don't Think Cannabis Is Uninvestable'
EXCLUSIVE: Cannabis ETF Leaders Highlight Convenience For Investors, Growth Opportunities — 'I Don't Think Cannabis Is Uninvestable'
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know
Is Now The Time To Invest In Cannabis Stocks? Trends And Long-Term Predictions From Industry Experts
Is Now The Time To Invest In Cannabis Stocks? Trends And Long-Term Predictions From Industry Experts
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know
Is Now The Time To Invest In Cannabis Stocks? Trends And Long-Term Predictions From Industry Experts
Is Now The Time To Invest In Cannabis Stocks? Trends And Long-Term Predictions From Industry Experts
Cannabis Now Surpasses Alcohol: 'This Trend Will Continue for Decades,' Says Expert
Cannabis Now Surpasses Alcohol: 'This Trend Will Continue for Decades,' Says Expert
Curious About ETFs? Learn How To Start Mastering The Market
Curious About ETFs? Learn How To Start Mastering The Market

Dan Ahrens Recent News

EXCLUSIVE: Cannabis Industry Optimization Takes Center Stage As Hyper Growth Slows
EXCLUSIVE: Cannabis Industry Optimization Takes Center Stage As Hyper Growth Slows
Cannabis is "not a one-year thing," it's a "multi-decade growth opportunity," Aaron Grey, head of consumer research at A.G.P./Alliance Global Partners, told a full room of attendees gathered at the
AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2X Daily ETF MSOX
AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2X Daily ETF MSOX
AdvisorShares revealed that the AdvisorShares MSOS 2x Daily ETF (ARCA:MSOX) will begin trading on August 24th.
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into a period of turmoil characterized by declining valuations and a generalized capital dry spell.
MSOs Cannabis ETF Manager Weighs In On Green Thumb Industries, Trulieve & Cresco Labs Post Earnings
MSOs Cannabis ETF Manager Weighs In On Green Thumb Industries, Trulieve & Cresco Labs Post Earnings
After an earnings-heavy week, where many of the largest cannabis companies reported their quarterly results, Benzinga caught up with Dan Ahrens, portfolio manager of the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) and the AdvisorShares Pure Cannabis ETF (
Investors Have Been Flocking To This US Cannabis ETF
Investors Have Been Flocking To This US Cannabis ETF
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. It only took six months for the newest cannabis ETF to reach $1 billion in assets.
This Cannabis ETF Focused Only On Domestic Securities Has Surpassed $1B In AUM
This Cannabis ETF Focused Only On Domestic Securities Has Surpassed $1B In AUM
"There's a lot of excitement surrounding the cannabis investment space right now and for a variety of a reasons," Dan Ahrens says.
An Excerpt From Dan Ahrens' Book On Investing In Cannabis: Canada Vs. The US
An Excerpt From Dan Ahrens' Book On Investing In Cannabis: Canada Vs. The US
Written by Dan Ahrens, chief operating officer and portfolio manager at AdvisorShares, and renowned “vice investing” expert, this new book examines the rapidly expanding world of cannabis investment.  Ahrens takes an in-depth look at all aspects of publicly traded stocks in the cannabis industry, as well as  explores the differences between the Canadian and U.S.
M1 Finance Closes On $45M Series C To Pursue Strategic Growth Initiatives
M1 Finance Closes On $45M Series C To Pursue Strategic Growth Initiatives
After surpassing $2 billion in assets one month ago, M1 Finance, an automated money management platform, announced the closure of a $45-million Series C funding round led by Left Lane Capital.
Managers Explain Their Cannabis ETFs: YOLO
Managers Explain Their Cannabis ETFs: YOLO
By Natan Ponieman and Javier Hasse. In this four-part series, Benzinga takes an exclusive look at some of the highest valued, US-traded cannabis ETFs.
ETF Spotlight On This Week's Benzinga Cannabis Hour
ETF Spotlight On This Week's Benzinga Cannabis Hour
Benzinga's Javier Hasse and Elliot Lane are gearing up for yet another exciting edition of The Benzinga Cannabis Hour, this Thursday, Sept. 10. Guests include:
As Cannabis Stocks Dip, Hexo Is Among The Worst, Cannabis ETF Manager Says
As Cannabis Stocks Dip, Hexo Is Among The Worst, Cannabis ETF Manager Says
As of June 22, Hexo (NYSE: HEXO) (TSE: HEXO) will no longer be listed on the S&P/TSX composite index.
3 Cannabis ETFs For 4/20
3 Cannabis ETFs For 4/20
After a rough year in 2019 (to put it mildly), cannabis stocks and the related exchange-traded funds are incurring significant punishment again this year.
The New Cannabis ETF Is Already Making Additions
The New Cannabis ETF Is Already Making Additions
YOLO? US Investors Are Getting Another Cannabis ETF
YOLO? US Investors Are Getting Another Cannabis ETF
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved